JOHN M HARLAN
Osteopathic Medicine at 9 Ave, Seattle, WA
License number
Washington MD00015218
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
325 9Th Ave, Seattle, WA 98104
Phone
(206) 731-3241
(206) 543-6420
(206) 543-6420
Personal information
See more information about JOHN M HARLAN at radaris.comName
Address
Phone
4905 NE 60Th St, Seattle, WA 98115
PO Box 27, Indianola, WA 98342
17791 Fjord Dr NE, Poulsbo, WA 98370
9023 Fletcher Blvd NE, Bainbridge Island, WA 98110
7950 Grand Ave NE, Bainbridge Island, WA 98110
Organization information
See more information about JOHN M HARLAN at bizstanding.comJohn M Harlan MD
325 9 Ave, Seattle, WA 98104
Categories:
Hematology Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Oncology Physicians & Surgeons
Phone:
(206) 744-3300 (Phone)
Professional information
John M Harlan, Seattle WA
Specialties:
Hematologist
Address:
325 9Th Ave, Seattle, WA 98104
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine*
University of Washington Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)*
UCSF Medical Center - Residency - Family Medicine*
University of Washington Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)*
UCSF Medical Center - Residency - Family Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)*
John Marshall Harlan, Seattle WA
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology
Work:
Harborview Medical Center Hematology Oncology Clinic
325 9Th Ave, Seattle, WA 98104
325 9Th Ave, Seattle, WA 98104
Education:
University of Chicago (1973)
Dr. John M Harlan, Seattle WA - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Harborview Medical Cntr Hem Onc
325 9Th Ave, Seattle 98104
(206) 744-3300 (Phone)
325 9Th Ave, Seattle 98104
(206) 744-3300 (Phone)
Certifications:
Hematology, 1978, Internal Medicine, 1976, Medical Oncology, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Harborview Medical Cntr Hem Onc
325 9Th Ave, Seattle 98104
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
325 9Th Ave, Seattle 98104
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1973
Ucsf Hosps
University Of Washington
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1973
Ucsf Hosps
University Of Washington
Methods And Compositions For Prevention Or Treatment Of Inflammatory-Related Diseases And Disorders
US Patent:
2007027, Nov 22, 2007
Filed:
May 18, 2006
Appl. No.:
11/437977
Inventors:
John M. Harlan - Seattle WA, US
Lynn M. Schnapp - Seattle WA, US
Barbara R. Schwartz - Seattle WA, US
Li Liu - Sammamish WA, US
Elaine White Raines - Seattle WA, US
Yoshiaki Tsubota - Seattle WA, US
Lynn M. Schnapp - Seattle WA, US
Barbara R. Schwartz - Seattle WA, US
Li Liu - Sammamish WA, US
Elaine White Raines - Seattle WA, US
Yoshiaki Tsubota - Seattle WA, US
Assignee:
The University of Washington - Seattle WA
International Classification:
A61K 48/00, A61K 31/55, A61K 39/395, A61K 31/522, A61K 31/517
US Classification:
514 44, 51426332, 514414, 514216, 51421401, 5142661, 4241331, 514 2
Abstract:
Methods and compositions are provided for treating inflammatory-related diseases and related disorders in a mammalian subject. The method provides administering to the mammalian subject one or more modulators of cyclin dependent kinase 4 (Cdk4) activity in an amount effective to reduce or eliminate the inflammatory-related disease or disorder or prevent its occurrence or recurrence. Methods are also provided for reducing or eliminating ligand-induced adhesion in a mammalian subject. The method provides administering to the subject one or more modulators of cyclin dependent kinase 4 (Cdk4) activity in an amount effective to reduce or eliminate ligand-induced adhesion.
Methods Of Inhibiting Cell Death Or Inflammation In A Mammal
US Patent:
2011026, Oct 27, 2011
Filed:
Nov 8, 2007
Appl. No.:
12/514436
Inventors:
John M. Harlan - Seattle WA, US
Robert K. Winn - Bainbridge Island WA, US
Robert K. Winn - Bainbridge Island WA, US
International Classification:
A61K 38/17, A61P 43/00, A61K 38/10
US Classification:
514 189
Abstract:
Methods are provided for inhibiting cell death or inflammation in a mammal concurrent with or after the onset of a condition expected to lead to cell death or inflammation. The methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. Methods are also provided for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal concurrent with or after the onset of a condition expected to lead to cell death or inflammation.
Methods Of Inhibiting Cell Death Or Inflammation In A Mammal By Administering A Bcl Protein
US Patent:
8304389, Nov 6, 2012
Filed:
May 13, 2011
Appl. No.:
13/107866
Inventors:
John M. Harlan - Seattle WA, US
Robert K. Winn - Bainbridge Island WA, US
Akiko Iwata - Seattle WA, US
Joan Tupper - Seattle WA, US
John Li - San Francisco CA, US
Robert K. Winn - Bainbridge Island WA, US
Akiko Iwata - Seattle WA, US
Joan Tupper - Seattle WA, US
John Li - San Francisco CA, US
Assignee:
University of Washington through its Center for Commercialization, a Public Institution of Higher Education - Seattle WA
International Classification:
A61K 38/16
US Classification:
514 187, 514 11, 514 212, 514 213
Abstract:
In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
Methods For Treating Or Preventing Heart Failure
US Patent:
2011002, Jan 27, 2011
Filed:
Feb 1, 2010
Appl. No.:
12/697978
Inventors:
John M. Harlan - Seattle WA, US
Robert K. Winn - Seattle WA, US
Akiko Iwata - Seattle WA, US
Robert K. Winn - Seattle WA, US
Akiko Iwata - Seattle WA, US
International Classification:
A61K 38/16, A61K 38/10, A61P 9/00
US Classification:
514 164
Abstract:
The invention provides methods for inhibiting cell death or inflammation in a mammal brought about by diseases or conditions such as heart failure, wherein the method comprises administering to a mammal in need thereof a Bcl protein in an amount sufficient to inhibit cell death and inflammation in the mammal.
Method Of Inhibiting Inflammation In A Mammal By Administering Bcl Protein
US Patent:
7964565, Jun 21, 2011
Filed:
Oct 4, 2005
Appl. No.:
11/576591
Inventors:
John M. Harlan - Seattle WA, US
Robert K. Winn - Bainbridge Island WA, US
Akiko Iwata - Seattle WA, US
Joan Tupper - Seattle WA, US
John Li - Santa Monica CA, US
Robert K. Winn - Bainbridge Island WA, US
Akiko Iwata - Seattle WA, US
Joan Tupper - Seattle WA, US
John Li - Santa Monica CA, US
Assignee:
University of Washington Center for Commercialization, a Public Institution of Higher Education - Seattle WA
International Classification:
A61K 38/16
US Classification:
514 187, 514 11, 514 212
Abstract:
In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
Therapy Or Prevention Of Diseases With Cells Or Cell Supernatant
US Patent:
2010029, Nov 25, 2010
Filed:
Feb 1, 2010
Appl. No.:
12/697982
Inventors:
John M. Harlan - Seattle WA, US
Robert K. Winn - Bainbridge Island WA, US
Robert K. Winn - Bainbridge Island WA, US
International Classification:
A61K 35/26, A61K 35/12, A61P 9/10, A61P 3/10, A61P 37/06, A61P 35/00, A61P 29/00, A61P 11/00
US Classification:
424 9371, 424 931, 424 937
Abstract:
Methods and compositions for the treatment or prevention of diseases or disorders including media conditioned by mesenchymal stem cells and BCL2A1 are provided. Methods for the production of therapeutic or preventative compositions contacted with BCL2A1 are also provided.
Methods And Compositions For Inhibiting Inflammation Associated With Pulmonary Disease
US Patent:
2001000, Jul 5, 2001
Filed:
Feb 17, 1999
Appl. No.:
09/251707
Inventors:
JOHN M. HARLAN - SEATTLE WA, US
ROBERT K. WINN - BAINBRIDGE ISLAND WA, US
LI LIU - REDMOND WA, US
ROBERT K. WINN - BAINBRIDGE ISLAND WA, US
LI LIU - REDMOND WA, US
Assignee:
UNIVERSITY OF WASHINGTON
International Classification:
A61K009/00
US Classification:
424/400000
Abstract:
The present invention provides an aerosol formulation of a 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor. The HMG-CoA reductase inhibitor can be, for example, a statin such as lovastatin, pravastatin, simvastatin, cerivastatin, fluvastatin, atorvastatin or mevastatin. The invention also provides a method of treating a pulmonary disease with an aerosol formulation of a HMG-CoA reductase inhibitor.